Boundless Bio Cash Flow Statement 2022-2024 | BOLD

Fifteen years of historical annual cash flow statements for Boundless Bio (BOLD).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022
$-49.43$-45.90
$0.96$0.94
$2.42$4.50
$3.38$5.44
$0$0
$0$0
$0$0
$-2.46$-1.05
$-0.80$0.87
$-46.86$-39.60
$-0.63$-1.07
$0$0
$0$0
$0$0
$-37.63$17.20
$-37.63$17.20
$0$0
$-38.26$16.13
$0$0
$0$0
$0$0
$0.18$0.13
$99.85$0.13
$0$0
$-1.96$0
$97.90$0.13
$12.78$-23.34
$3.34$2.29
$0$0